Xspray Pharma AB (publ) (XSPRAY.ST)
SEK 26.5
(1.73%)
SEK 26.5
(1.73%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -6.76 SEK | -10.28% |
| 2022 | -6.13 SEK | -23.09% |
| 2021 | -4.98 SEK | -65.45% |
| 2020 | -3.01 SEK | -0.67% |
| 2019 | -2.99 SEK | -77.98% |
| 2018 | -1.68 SEK | -1.82% |
| 2017 | -1.65 SEK | -157.81% |
| 2016 | -0.64 SEK | 34.02% |
| 2015 | -0.97 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -2.17 SEK | -17.3% |
| 2024 Q2 | -1.64 SEK | 24.42% |
| 2023 FY | - SEK | -10.28% |
| 2023 Q3 | -1.59 SEK | 29.96% |
| 2023 Q1 | -1.50 SEK | 38.78% |
| 2023 Q2 | -2.27 SEK | -51.33% |
| 2023 Q4 | -1.85 SEK | -16.35% |
| 2022 FY | - SEK | -23.09% |
| 2022 Q4 | -2.45 SEK | -78.83% |
| 2022 Q2 | -1.38 SEK | -53.33% |
| 2022 Q3 | -1.37 SEK | 0.72% |
| 2022 Q1 | -0.90 SEK | 66.67% |
| 2021 Q1 | -0.73 SEK | 17.98% |
| 2021 FY | - SEK | -65.45% |
| 2021 Q2 | -0.88 SEK | -20.55% |
| 2021 Q3 | -0.72 SEK | 18.18% |
| 2021 Q4 | -2.70 SEK | -275.0% |
| 2020 Q4 | -0.89 SEK | -30.88% |
| 2020 FY | - SEK | -0.67% |
| 2020 Q3 | -0.68 SEK | 25.27% |
| 2020 Q2 | -0.91 SEK | -46.77% |
| 2020 Q1 | -0.62 SEK | 40.38% |
| 2019 Q2 | -0.73 SEK | -30.36% |
| 2019 Q1 | -0.56 SEK | 27.27% |
| 2019 Q3 | -0.70 SEK | 4.11% |
| 2019 FY | - SEK | -77.98% |
| 2019 Q4 | -1.04 SEK | -48.57% |
| 2018 Q4 | -0.77 SEK | -156.67% |
| 2018 Q1 | -0.12 SEK | 68.42% |
| 2018 FY | - SEK | -1.82% |
| 2018 Q2 | -0.50 SEK | -316.67% |
| 2018 Q3 | -0.30 SEK | 40.0% |
| 2017 Q4 | -0.38 SEK | -65.22% |
| 2017 Q1 | -1.00 SEK | -140.65% |
| 2017 Q2 | 0.11 SEK | 111.0% |
| 2017 FY | - SEK | -157.81% |
| 2017 Q3 | -0.23 SEK | -309.09% |
| 2016 Q1 | -1.08 SEK | 0.0% |
| 2016 FY | - SEK | 34.02% |
| 2016 Q3 | -1.05 SEK | 2.78% |
| 2016 Q4 | 2.46 SEK | 334.29% |
| 2016 Q2 | -1.08 SEK | 0.0% |
| 2015 FY | - SEK | 0.0% |